Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3761898015 | Cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 mg prolonged-release oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3761899011 | Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) | Is a | Product containing cyclobenzaprine (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) | Has active ingredient | Cyclobenzaprine hydrochloride | false | Inferred relationship | Some | ||
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) | Has manufactured dose form | Capsule | false | Inferred relationship | Some | ||
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) | Has manufactured dose form | Oral capsule | false | Inferred relationship | Some | ||
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) | Has active ingredient | Cyclobenzaprine (substance) | false | Inferred relationship | Some | ||
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) | Has manufactured dose form | Extended-release capsule | false | Inferred relationship | Some | ||
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) | Has manufactured dose form | Prolonged-release oral capsule | false | Inferred relationship | Some | ||
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) | Is a | Cyclobenzaprine-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some | ||
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | false | Inferred relationship | Some | 1 | |
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) | Has unit of presentation | Capsule (unit of presentation) | false | Inferred relationship | Some | ||
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) | Count of base of active ingredient | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) | Has presentation strength numerator value | 15 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) | Has precise active ingredient | Cyclobenzaprine hydrochloride | false | Inferred relationship | Some | 1 | |
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Cyclobenzaprine (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) | Is a | Product containing only cyclobenzaprine in oral dose form (medicinal product form) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR